{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:01:25Z","timestamp":1793228485342,"version":"4.5.0"},"reference-count":349,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1124\/pr.115.011106","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T21:33:15Z","timestamp":1450128795000},"page":"49-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":333,"title":["Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology"],"prefix":"10.1016","volume":"68","author":[{"given":"F.","family":"Jaisser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Farman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.115.011106_bib1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00210-014-1048-3","article-title":"Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats","volume":"387","author":"Adel","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.115.011106_bib2","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1124\/pr.115.011106_bib3","article-title":"Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration","author":"Amador","year":"2015","journal-title":"Kidney Int"},{"key":"10.1124\/pr.115.011106_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib5","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.722009","article-title":"Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells","volume":"116","author":"Ambroisine","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1681\/ASN.2014010117","article-title":"Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis","volume":"25","author":"Anders","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(14)70194-9","article-title":"Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial","volume":"2","author":"Ando","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1124\/pr.115.011106_bib8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1365-2133.2009.09293.x","article-title":"Elevated aldosterone levels in patients with androgenetic alopecia","volume":"161","author":"Arias-Santiago","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1124\/pr.115.011106_bib9","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1096\/fj.13-245415","article-title":"Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice","volume":"28","author":"Armani","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/14656566.2014.896901","article-title":"Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs","volume":"15","author":"Armanini","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/pr.115.011106_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1124\/pr.115.011106_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pr.115.011106_bib13","doi-asserted-by":"crossref","first-page":"H41","DOI":"10.1152\/ajpheart.00637.2010","article-title":"Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization","volume":"301","author":"Bafford","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pr.115.011106_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"10.1124\/pr.115.011106_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005344-200307000-00005","article-title":"Effect of canrenone on the digitalis site of Na+\/K(+)-ATPase in human placental membranes and in erythrocytes","volume":"42","author":"Balzan","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.115.011106_bib16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/ijbs.11729","article-title":"Mild ischemic injury leads to long-term alterations in the kidney: amelioration by spironolactone administration","volume":"11","author":"Barrera-Chimal","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1124\/pr.115.011106_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2012.352","article-title":"Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury","volume":"83","author":"Barrera-Chimal","year":"2013","journal-title":"Kidney Int"},{"key":"10.1124\/pr.115.011106_bib18","article-title":"Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia","author":"Barrera-Chimal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.HYP.0000226055.65364.8e","article-title":"Endothelial NO synthase target of aldosterone","volume":"48","author":"Bauersachs","year":"2006","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1470320310391330","article-title":"Eplerenone suppresses aldosterone\/ salt-induced expression of NOX-4","volume":"12","author":"Bayorh","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1124\/pr.115.011106_bib22","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/HYPERTENSIONAHA.114.04912","article-title":"Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction","volume":"65","author":"Bender","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db14-1425","article-title":"Mineralocorticoid receptors: an appealing target to treat coronary microvascular dysfunction in diabetes","volume":"64","author":"Bender","year":"2015","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.011106_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","article-title":"Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?","volume":"62","author":"Bender","year":"2013","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.011106_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2014.04.005","article-title":"Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease","volume":"91","author":"Bene","year":"2014","journal-title":"Steroids"},{"key":"10.1124\/pr.115.011106_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1469-7793.2001.0151k.x","article-title":"Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes","volume":"537","author":"B\u00e9nitah","year":"2001","journal-title":"J Physiol"},{"key":"10.1124\/pr.115.011106_bib27","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.RES.85.12.1139","article-title":"Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes","volume":"85","author":"B\u00e9nitah","year":"1999","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011106_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/HYPERTENSIONAHA.109.141309","article-title":"Aldosterone abrogates nuclear factor kappaB-mediated tumor necrosis factor alpha production in human neutrophils via the mineralocorticoid receptor","volume":"55","author":"Bergmann","year":"2010","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ki.2011.48","article-title":"Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease","volume":"79","author":"Bertocchio","year":"2011","journal-title":"Kidney Int"},{"key":"10.1124\/pr.115.011106_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2011.11.076","article-title":"Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia","volume":"167","author":"Beygui","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1124\/pr.115.011106_bib31","doi-asserted-by":"crossref","first-page":"F2","DOI":"10.1152\/ajprenal.00072.2007","article-title":"New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone","volume":"293","author":"Bobadilla","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/187569211798377135","article-title":"Top three pharmacogenomics and personalized medicine applications at the nexus of renal pathophysiology and cardiovascular medicine","volume":"9","author":"Bochud","year":"2011","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"10.1124\/pr.115.011106_bib33","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease","volume":"4","author":"Bolignano","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011106_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"10.1124\/pr.115.011106_bib35","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"10.1124\/pr.115.011106_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049036","article-title":"The aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitis","volume":"7","author":"Bousquet","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011106_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s000590050024","article-title":"Aldosterone and myocardial fibrosis in heart failure","volume":"25","author":"Brilla","year":"2000","journal-title":"Herz"},{"issue":"5, Suppl","key":"10.1124\/pr.115.011106_bib38","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/BF00180074","article-title":"Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation","volume":"71","author":"Brilla","year":"1993","journal-title":"Clin Investig"},{"key":"10.1124\/pr.115.011106_bib39","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1124\/pr.115.011106_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib41","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1242\/jcs.112.19.3343","article-title":"Epithelial sodium channel in human epidermal keratinocytes: expression of its subunits and relation to sodium transport and differentiation","volume":"112","author":"Brouard","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1124\/pr.115.011106_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/pr.115.011106_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1124\/pr.115.011106_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011106_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ajh\/hps080","article-title":"Age-related changes in 11\u03b2-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects","volume":"26","author":"Campino","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1124\/pr.115.011106_bib46","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011106_bib48","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1592\/phco.24.8.750.36076","article-title":"Racial differences in patients\u2019 potassium concentrations during spironolactone therapy for heart failure","volume":"24","author":"Cavallari","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1124\/pr.115.011106_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1470320308096367","article-title":"Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression","volume":"9","author":"Cavallari","year":"2008","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1124\/pr.115.011106_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.30.1.1","article-title":"Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure","volume":"30","author":"Cavallari","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1124\/pr.115.011106_bib51","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/HJH.0b013e328335c381","article-title":"Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?","volume":"28","author":"Chai","year":"2010","journal-title":"J Hypertens"},{"key":"10.1124\/pr.115.011106_bib52","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.115.011106_bib53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011106_bib54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/13543776.2014.854772","article-title":"Mineralocorticoid receptor modulators: a patent review (2007-2012)","volume":"24","author":"Collin","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/pr.115.011106_bib55","first-page":"114","article-title":"Influence of adrenal cortical steroids on carbohydrate metabolism in man","volume":"5","author":"Conn","year":"1956","journal-title":"Metabolism"},{"key":"10.1124\/pr.115.011106_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am J Surg"},{"key":"10.1124\/pr.115.011106_bib57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/202298a0","article-title":"Action of aldosterone on the bladder and skin of the toad","volume":"202","author":"Crabbe","year":"1964","journal-title":"Nature"},{"key":"10.1124\/pr.115.011106_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/dmd.108.023721","article-title":"Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice","volume":"37","author":"Cui","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.115.011106_bib59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/pgs.14.163","article-title":"Impact of mineralocorticoid receptor polymorphisms on urinary electrolyte excretion with and without diuretic drugs","volume":"16","author":"Dalila","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1124\/pr.115.011106_bib60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2011.06.100","article-title":"Aldosterone induces electrical remodeling independent of hypertension","volume":"164","author":"Dartsch","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1124\/pr.115.011106_bib61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1124\/pr.115.011106_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/clc.20689","article-title":"Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation","volume":"33","author":"De-An","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1124\/pr.115.011106_bib63","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/01.ATV.0000181743.28028.57","article-title":"Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury","volume":"25","author":"De Ciuceis","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011106_bib64","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/physrev.00035.2005","article-title":"Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins","volume":"86","author":"Deeley","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.115.011106_bib65","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/en.2014-1048","article-title":"From receptor balance to rational glucocorticoid therapy","volume":"155","author":"de Kloet","year":"2014","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10739680490266207","article-title":"Enhancement of glucocorticoid and mineralocorticoid receptor density in the microcirculation of the spontaneously hypertensive rat","volume":"11","author":"DeLano","year":"2004","journal-title":"Microcirculation"},{"key":"10.1124\/pr.115.011106_bib67","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.114.303792","article-title":"Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaC\u03b1, and the renin-angiotensin-aldosterone system","volume":"34","author":"Deliyanti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011106_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.05674","article-title":"Low-dose mineralocorticoid receptor blockade prevents Western diet-induced arterial stiffening in female mice","volume":"66","author":"DeMarco","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3317\/jraas.2006.005","article-title":"Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart","volume":"7","author":"De Mello","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1124\/pr.115.011106_bib70","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1210\/jc.2006-0915","article-title":"A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness","volume":"91","author":"DeRijk","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.011106_bib71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/FJC.0b013e31822a78c1","article-title":"Spironolactone prevents the inducibility of ventricular tachyarrhythmia in rats with aldosteronism","volume":"58","author":"Deshmukh","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.115.011106_bib72","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1111\/j.1467-789X.2010.00811.x","article-title":"Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue","volume":"12","author":"Divoux","year":"2011","journal-title":"Obes Rev"},{"key":"10.1124\/pr.115.011106_bib73","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","article-title":"Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling","volume":"52","author":"Di Zhang","year":"2008","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib74","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2741\/3697","article-title":"The regulation of cell growth and survival by aldosterone","volume":"16","author":"Dooley","year":"2011","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1124\/pr.115.011106_bib75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.07.019","article-title":"Non-genomic actions of aldosterone: from receptors and signals to membrane targets","volume":"350","author":"Dooley","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib76","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/ehs361","article-title":"Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients","volume":"34","author":"Drechsler","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011106_bib77","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fphys.2012.00341","article-title":"\u03b2ENaC is a molecular component of a VSMC mechanotransducer that contributes to renal blood flow regulation, protection from renal injury, and hypertension","volume":"3","author":"Drummond","year":"2012","journal-title":"Front Physiol"},{"key":"10.1124\/pr.115.011106_bib78","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/HYPERTENSIONAHA.113.01273","article-title":"Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney","volume":"63","author":"DuPont","year":"2014","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib79","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00424-010-0817-1","article-title":"Endothelium-derived hyperpolarising factors and associated pathways: a synopsis","volume":"459","author":"Edwards","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.115.011106_bib80","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011106_bib81","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jtcvs.2012.08.007","article-title":"Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice","volume":"145","author":"Ehsan","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1124\/pr.115.011106_bib82","doi-asserted-by":"crossref","first-page":"C1482","DOI":"10.1152\/ajpcell.1997.272.5.C1482","article-title":"Noncoordinate regulation of epithelial Na channel and Na pump subunit mRNAs in kidney and colon by aldosterone","volume":"272","author":"Escoubet","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011106_bib83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/hmbci-2014-0013","article-title":"Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR\/GR)","volume":"19","author":"Even","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1124\/pr.115.011106_bib84","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","article-title":"Primary aldosteronism and metabolic syndrome","volume":"44","author":"Fallo","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1124\/pr.115.011106_bib85","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1210\/en.2010-0829","article-title":"Aldosterone\/mineralocorticoid receptor stimulation induces cellular senescence in the kidney","volume":"152","author":"Fan","year":"2011","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jsbmb.2014.04.015","article-title":"Post-translational modifications of the mineralocorticoid receptor: How to dress the receptor according to the circumstances?","volume":"143","author":"Faresse","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/pr.115.011106_bib87","doi-asserted-by":"crossref","first-page":"F1462","DOI":"10.1152\/ajprenal.00285.2010","article-title":"Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP","volume":"299","author":"Faresse","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib88","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1096\/fj.12-209924","article-title":"Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation","volume":"26","author":"Faresse","year":"2012","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib89","first-page":"F99","article-title":"Aldosterone binding in isolated tubules. IV. Autoradiography along the nephron of the spontaneously hypertensive rat","volume":"249","author":"Farman","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011106_bib90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0625.2009.01011.x","article-title":"The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?","volume":"19","author":"Farman","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1124\/pr.115.011106_bib91","doi-asserted-by":"crossref","first-page":"C226","DOI":"10.1152\/ajpcell.1991.260.2.C226","article-title":"Immunolocalization of gluco- and mineralocorticoid receptors in rabbit kidney","volume":"260","author":"Farman","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011106_bib92","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"Farman","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib93","first-page":"F69","article-title":"Aldosterone binding in isolated tubules II. An autoradiographic study of concentration dependency in the rabbit nephron","volume":"242","author":"Farman","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011106_bib94","first-page":"F235","article-title":"Autoradiographic study of aldosterone and dexamethasone binding in isolated glomeruli of rabbit kidney","volume":"243","author":"Farman","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011106_bib95","first-page":"H2035","article-title":"Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression","volume":"300","author":"Favre","year":"2011","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011106_bib96","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1096\/fj.13-239822","article-title":"Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice","volume":"28","author":"Fazal","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib97","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF03346627","article-title":"Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels","volume":"33","author":"Fernandes-Rosa","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"10.1124\/pr.115.011106_bib98","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.HYP.35.1.464","article-title":"Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension","volume":"35","author":"Fink","year":"2000","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib99","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0022-3565(25)32607-8","article-title":"Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase","volume":"217","author":"Finotti","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.011106_bib100","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients","volume":"41","author":"Flack","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.115.011106_bib101","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.preteyeres.2010.03.003","article-title":"The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature","volume":"29","author":"Fletcher","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1124\/pr.115.011106_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/395278","article-title":"Danger signals in cardiovascular disease","volume":"2014","author":"Frantz","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1124\/pr.115.011106_bib103","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1085\/jgp.200809989","article-title":"Surface expression of epithelial Na channel protein in rat kidney","volume":"131","author":"Frindt","year":"2008","journal-title":"J Gen Physiol"},{"key":"10.1124\/pr.115.011106_bib104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/clpt.2011.227","article-title":"Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension","volume":"91","author":"Fujimura","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.115.011106_bib105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/JOE-11-0372","article-title":"Mechanisms of ligand specificity of the mineralocorticoid receptor","volume":"213","author":"Fuller","year":"2012","journal-title":"J Endocrinol"},{"key":"10.1124\/pr.115.011106_bib106","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib107","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib108","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/HYPERTENSIONAHA.113.01967","article-title":"Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness","volume":"63","author":"Galmiche","year":"2014","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib109","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-2362.2012.02676.x","article-title":"Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances","volume":"42","author":"Galuppo","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/pr.115.011106_bib110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MED.0b013e3283533955","article-title":"Role of mineralocorticoid receptor in insulin resistance","volume":"19","author":"Garg","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1124\/pr.115.011106_bib111","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/db14-0670","article-title":"Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes","volume":"64","author":"Garg","year":"2015","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.011106_bib112","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib113","doi-asserted-by":"crossref","first-page":"F559","DOI":"10.1152\/ajprenal.90399.2008","article-title":"Aldosterone in the brain","volume":"297","author":"Geerling","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib114","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1124\/pr.115.011106_bib115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yexcr.2014.11.004","article-title":"Aldosterone up-regulates MMP-9 and MMP-9\/NGAL expression in human neutrophils through p38, ERK1\/2 and PI3K pathways","volume":"331","author":"Gilet","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1124\/pr.115.011106_bib116","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0002-9149(01)01905-1","article-title":"Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation","volume":"88","author":"Goette","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1124\/pr.115.011106_bib117","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/CIRCULATIONAHA.108.805804","article-title":"Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins","volume":"119","author":"G\u00f3mez","year":"2009","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib118","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/1570161111311040013","article-title":"Ca(2+) fluxes involvement in gene expression during cardiac hypertrophy","volume":"11","author":"G\u00f3mez","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1124\/pr.115.011106_bib119","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/HYPERTENSIONAHA.115.05148","article-title":"What is the role of the adipocyte mineralocorticoid receptor in the metabolic syndrome?","volume":"66","author":"Gomez-Sanchez","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.steroids.2014.08.014","article-title":"Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis","volume":"91","author":"Gomez-Sanchez","year":"2014","journal-title":"Steroids"},{"key":"10.1124\/pr.115.011106_bib121","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.transproceed.2010.08.024","article-title":"Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months","volume":"42","author":"Gonz\u00e1lez Monte","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1124\/pr.115.011106_bib122","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1549-8719.2009.00015.x","article-title":"Microvascular responses to cardiovascular risk factors","volume":"17","author":"Granger","year":"2010","journal-title":"Microcirculation"},{"key":"10.1124\/pr.115.011106_bib123","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001266","article-title":"Aldosterone promotes cardiac endothelial cell proliferation in vivo","volume":"4","author":"Gravez","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pr.115.011106_bib124","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.ajkd.2005.03.005","article-title":"Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients","volume":"46","author":"Gross","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/pr.115.011106_bib125","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"G\u00fcder","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib126","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardfail.2014.12.011","article-title":"Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism","volume":"21","author":"G\u00fcder","year":"2015","journal-title":"J Card Fail"},{"key":"10.1124\/pr.115.011106_bib127","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib128","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib129","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-3565(25)23337-7","article-title":"Effect of canrenone on the disturbances of cation handling induced by ouabain in macrophages and vascular smooth muscle cells","volume":"239","author":"Hannaert","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.011106_bib130","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1995.402","article-title":"Cross-talk between sodium and potassium channels in tight epithelia","volume":"48","author":"Harvey","year":"1995","journal-title":"Kidney Int"},{"key":"10.1124\/pr.115.011106_bib131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-5793(99)01667-1","article-title":"Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors","volume":"464","author":"Hellal-Levy","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.115.011106_bib132","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/mend.14.8.0502","article-title":"Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor","volume":"14","author":"Hellal-Levy","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/pr.115.011106_bib133","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2008.152","article-title":"Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients","volume":"21","author":"Henschkowski","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1124\/pr.115.011106_bib134","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/HJH.0b013e32834a4c75","article-title":"Aldosterone as a modulator of immunity: implications in the organ damage","volume":"29","author":"Herrada","year":"2011","journal-title":"J Hypertens"},{"key":"10.1124\/pr.115.011106_bib135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011106_bib136","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pr.115.011106_bib137","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbrc.2012.01.139","article-title":"Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction","volume":"419","author":"Hirata","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011106_bib138","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2014.348","article-title":"Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans","volume":"87","author":"Hosoya","year":"2015","journal-title":"Kidney Int"},{"key":"10.1124\/pr.115.011106_bib139","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2012111094","article-title":"Myeloid mineralocorticoid receptor activation contributes to progressive kidney disease","volume":"25","author":"Huang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mce.2011.07.035","article-title":"Structural determinants of ligand binding to the mineralocorticoid receptor","volume":"350","author":"Huyet","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib141","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib142","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1681\/ASN.2013030273","article-title":"Long-term effects of spironolactone in peritoneal dialysis patients","volume":"25","author":"Ito","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib143","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.amjcard.2012.12.020","article-title":"Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation","volume":"111","author":"Ito","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1124\/pr.115.011106_bib144","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/en.2007-0864","article-title":"Aldosterone induces superoxide generation via Rac1 activation in endothelial cells","volume":"149","author":"Iwashima","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011106_bib146","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.ATV.0000258414.59393.89","article-title":"Mineralocorticoid receptor activation promotes vascular cell calcification","volume":"27","author":"Jaffe","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011106_bib147","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/HYPERTENSIONAHA.110.164962","article-title":"The mineralocorticoid receptor in heart: different effects in different cells","volume":"57","author":"Jaisser","year":"2011","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib148","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/HYPERTENSIONAHA.111.199455","article-title":"Epithelial sodium channel stiffens the vascular endothelium in vitro and in Liddle mice","volume":"61","author":"Jeggle","year":"2013","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib149","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1073\/pnas.0804037106","article-title":"Aldosterone activates endothelial exocytosis","volume":"106","author":"Jeong","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011106_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2007.10.005","article-title":"The coming out of the brain mineralocorticoid receptor","volume":"31","author":"Jo\u00ebls","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1124\/pr.115.011106_bib151","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2007-0393","article-title":"Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus","volume":"92","author":"Joffe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.011106_bib152","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib153","article-title":"Mineralocorticoid receptor antagonism in AKI: a new hope?","author":"Juncos","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib154","first-page":"414","article-title":"Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism","volume":"53","author":"Kamalov","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.115.011106_bib155","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.2174\/13816128113196660748","article-title":"eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammation","volume":"20","author":"Karbach","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.115.011106_bib156","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","article-title":"T regulatory lymphocytes prevent aldosterone-induced vascular injury","volume":"59","author":"Kasal","year":"2012","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib157","article-title":"Angiotensin II, aldosterone, and anti-inflammatory lymphocytes: interplay and therapeutic opportunities","volume":"2012","author":"Kasal","year":"2012","journal-title":"Int J Hypertens"},{"key":"10.1124\/pr.115.011106_bib158","first-page":"1334","article-title":"Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase","volume":"79","author":"Kenouch","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.011106_bib159","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/hr.2010.277","article-title":"Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats","volume":"34","author":"Kimura","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1124\/pr.115.011106_bib160","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/hr.2011.119","article-title":"Aldosterone-induced osteopontin gene transcription in vascular smooth muscle cells involves glucocorticoid response element","volume":"34","author":"Kiyosue","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1124\/pr.115.011106_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.115.011106_bib162","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.0000157408.43807.5a","article-title":"Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib163","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mce.2011.06.025","article-title":"Molecular pharmacology of the mineralocorticoid receptor: prospects for novel therapeutics","volume":"350","author":"Kolkhof","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib164","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.115.011106_bib165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0960-0760(03)00198-5","article-title":"The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat","volume":"85","author":"Konishi","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/pr.115.011106_bib166","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/HYPERTENSIONAHA.109.148783","volume":"55","author":"Krug","year":"2010","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib167","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00424-007-0341-0","article-title":"Aldosterone and amiloride alter ENaC abundance in vascular endothelium","volume":"455","author":"Kusche-Vihrog","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.115.011106_bib168","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib169","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/cvr\/cvn353","article-title":"Genetics and pathophysiology of arterial stiffness","volume":"81","author":"Lacolley","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pr.115.011106_bib170","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.CIR.0000039328.33137.6C","article-title":"Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone","volume":"106","author":"Lacolley","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib171","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1096\/fj.13-238188","article-title":"Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice","volume":"28","author":"Lagrange","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101584","article-title":"Clock genes and behavioral responses to light are altered in a mouse model of diabetic retinopathy","volume":"9","author":"Lahouaoui","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011106_bib173","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardiores.2005.05.009","article-title":"Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes","volume":"67","author":"Lalev\u00e9e","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pr.115.011106_bib174","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4149\/gpb_2011_01_11","article-title":"Effects of aldosterone and mineralocorticoid receptor antagonism on cardiac ion channels in the view of upstream therapy of atrial fibrillation","volume":"30","author":"Laszlo","year":"2011","journal-title":"Gen Physiol Biophys"},{"key":"10.1124\/pr.115.011106_bib175","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/HYPERTENSIONAHA.111.187872","article-title":"Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system","volume":"59","author":"Latouche","year":"2012","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib176","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011106_bib177","article-title":"Histone deacetylase 3 and 4 complex stimulates the transcriptional activity of the mineralocorticoid receptor","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011106_bib178","doi-asserted-by":"crossref","first-page":"F1381","DOI":"10.1152\/ajprenal.00101.2009","article-title":"Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions","volume":"297","author":"Lee","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib179","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/CIRCRESAHA.109.196576","article-title":"Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors","volume":"105","author":"Lemari\u00e9","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011106_bib180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/cvr\/cvq087","article-title":"Mineralocorticoid receptor overexpression in embryonic stem cell-derived cardiomyocytes increases their beating frequency","volume":"87","author":"Le Menuet","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pr.115.011106_bib181","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/HYPERTENSIONAHA.115.05479","article-title":"The central role of neutrophil gelatinase-associated lipocalin in cardiovascular fibrosis","volume":"66","author":"Leopold","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib182","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity","volume":"13","author":"Leopold","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/pr.115.011106_bib183","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1084\/jem.20122292","article-title":"Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXR\u03b3 activation","volume":"210","author":"Leung","year":"2013","journal-title":"J Exp Med"},{"key":"10.1124\/pr.115.011106_bib184","article-title":"Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011106_bib185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1470320312460071","article-title":"Changes in microRNAs associated with podocytic adhesion damage under mechanical stress","volume":"14","author":"Li","year":"2013","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1124\/pr.115.011106_bib186","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","article-title":"Molecular mechanisms of human hypertension","volume":"104","author":"Lifton","year":"2001","journal-title":"Cell"},{"key":"10.1124\/pr.115.011106_bib187","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exer.2011.12.012","article-title":"Activation of the aldosterone\/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury","volume":"96","author":"Liu","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1124\/pr.115.011106_bib188","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lomb\u00e8s","year":"1992","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011106_bib189","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.108.125278","article-title":"Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure","volume":"53","author":"L\u00f3pez","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib190","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/en.2008-0120","article-title":"Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes","volume":"149","author":"L\u00f3pez-Andr\u00e9s","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib191","doi-asserted-by":"crossref","first-page":"H2372","DOI":"10.1152\/ajpheart.00283.2011","article-title":"A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone","volume":"301","author":"L\u00f3pez-Andr\u00e9s","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pr.115.011106_bib192","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/pgs.13.173","article-title":"Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatment","volume":"15","author":"Luo","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1124\/pr.115.011106_bib193","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"10.1124\/pr.115.011106_bib194","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s00125-011-2158-9","article-title":"Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets","volume":"54","author":"Luther","year":"2011","journal-title":"Diabetologia"},{"key":"10.1124\/pr.115.011106_bib195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073385","article-title":"Acute stress alters amygdala microRNA miR-135a and miR-124 expression: inferences for corticosteroid dependent stress response","volume":"8","author":"Mannironi","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011106_bib196","doi-asserted-by":"crossref","first-page":"39232","DOI":"10.1074\/jbc.M407436200","article-title":"Gain of function mutation in the mineralocorticoid receptor of the Brown Norway rat","volume":"279","author":"Marissal-Arvy","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011106_bib197","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/pr.115.011106_bib198","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.109.895235","article-title":"Aldosterone receptor antagonists: effective but often forgotten","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib199","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.113.007690","article-title":"Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis","volume":"130","author":"Maron","year":"2014","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib200","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.amjcard.2013.04.051","article-title":"Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials)","volume":"112","author":"Maron","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1124\/pr.115.011106_bib201","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.112.094722","article-title":"Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension","volume":"126","author":"Maron","year":"2012","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib202","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1210\/en.2009-0847","article-title":"In utero exposure to di-(2-ethylhexyl) phthalate decreases mineralocorticoid receptor expression in the adult testis","volume":"150","author":"Martinez-Arguelles","year":"2009","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.steroids.2014.05.001","article-title":"Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome","volume":"91","author":"Marzolla","year":"2014","journal-title":"Steroids"},{"key":"10.1124\/pr.115.011106_bib204","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.115.011106_bib205","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/jid.2015.44","article-title":"Topical mineralocorticoid receptor blockade limits glucocorticoid-induced epidermal atrophy in human skin","volume":"135","author":"Maubec","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1124\/pr.115.011106_bib206","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1523-1747.2002.01721.x","article-title":"The ENaC channel is required for normal epidermal differentiation","volume":"118","author":"Mauro","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1124\/pr.115.011106_bib207","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejim.2013.11.007","article-title":"Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review","volume":"25","author":"Mavrakanas","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1124\/pr.115.011106_bib208","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.ijcard.2013.08.022","article-title":"Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural\/electrical remodeling","volume":"168","author":"Mayyas","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1124\/pr.115.011106_bib209","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"key":"10.1124\/pr.115.011106_bib210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000018","article-title":"Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism","volume":"2","author":"McGraw","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pr.115.011106_bib211","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.steroids.2014.05.017","article-title":"Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators","volume":"91","author":"Meinel","year":"2014","journal-title":"Steroids"},{"key":"10.1124\/pr.115.011106_bib212","doi-asserted-by":"crossref","first-page":"F78","DOI":"10.1152\/ajprenal.00077.2007","article-title":"Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone","volume":"293","author":"Mej\u00eda-Vilet","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2003.10.008","article-title":"The 45-year story of the development of an anti-aldosterone more specific than spironolactone","volume":"217","author":"M\u00e9nard","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib214","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/HYPERTENSIONAHA.112.198986","article-title":"Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo","volume":"61","author":"Messaoudi","year":"2013","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib215","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1096\/fj.08-125302","article-title":"Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density","volume":"23","author":"Messaoudi","year":"2009","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib216","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/en.2004-1130","article-title":"Eplerenone blocks nongenomic effects of aldosterone on the Na+\/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels","volume":"146","author":"Michea","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib217","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000127112.36796.9B","article-title":"Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway","volume":"109","author":"Michel","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib218","first-page":"745","article-title":"Enhanced expression of mineralocorticoid receptors in the heart after the myocardial infarct in rats","volume":"58","author":"Milik","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/pr.115.011106_bib219","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.115.011106_bib220","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cardiores.2007.07.008","article-title":"Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence","volume":"76","author":"Min","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pr.115.011106_bib221","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.114.03449","article-title":"Arterial stiffness and hypertension: chicken or egg?","volume":"64","author":"Mitchell","year":"2014","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib222","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/jid.2010.155","article-title":"Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin","volume":"130","author":"Mitts","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1124\/pr.115.011106_bib223","first-page":"1163","article-title":"Molecular basis of mineralocorticoid receptor action in the nervous system","volume":"12","author":"Molinari","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1124\/pr.115.011106_bib224","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011106_bib225","article-title":"Endothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure","author":"Mueller","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib226","doi-asserted-by":"crossref","first-page":"H2710","DOI":"10.1152\/ajpheart.01399.2006","article-title":"Aldosterone modulates I(f) current through gene expression in cultured neonatal rat ventricular myocytes","volume":"293","author":"Muto","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pr.115.011106_bib227","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrneph.2012.282","article-title":"Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease","volume":"9","author":"Nagase","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/pr.115.011106_bib228","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","article-title":"Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors","volume":"17","author":"Nagase","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib229","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/acel.12017","article-title":"Aging-like skin changes in metabolic syndrome model mice are mediated by mineralocorticoid receptor signaling","volume":"12","author":"Nagase","year":"2013","journal-title":"Aging Cell"},{"key":"10.1124\/pr.115.011106_bib230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-2952(85)90123-6","article-title":"Relative inhibitory potency of five mineralocorticoid antagonists on aldosterone biosynthesis in vitro","volume":"34","author":"Netchitailo","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.115.011106_bib231","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/ATVBAHA.111.229070","article-title":"Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways","volume":"31","author":"Newfell","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011106_bib232","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1096\/fj.09-147926","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Nguyen Dinh Cat","year":"2010","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib233","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MNH.0b013e32834fb25b","article-title":"Extrarenal effects of aldosterone","volume":"21","author":"Nguyen Dinh Cat","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/pr.115.011106_bib234","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1124\/pr.115.011106_bib235","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.HYP.0000154681.38944.9a","article-title":"Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability","volume":"45","author":"Nishiyama","year":"2005","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib236","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.240","article-title":"Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma","volume":"4","author":"Nitta","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1124\/pr.115.011106_bib237","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ajh.2011.92","article-title":"SNPs in microRNA binding sites in 3\u2032-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction","volume":"24","author":"Nossent","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1124\/pr.115.011106_bib238","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mce.2011.07.020","article-title":"Tissue-specific modulation of mineralocorticoid receptor function by 11\u03b2-hydroxysteroid dehydrogenases: an overview","volume":"350","author":"Odermatt","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib239","doi-asserted-by":"crossref","first-page":"R946","DOI":"10.1152\/ajpregu.00402.2006","article-title":"Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker","volume":"292","author":"Ohtani","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.115.011106_bib240","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000350539","article-title":"Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: a double-blind, randomized pilot study","volume":"37","author":"Ojeda-Cervantes","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1124\/pr.115.011106_bib241","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias","volume":"111","author":"Ouvrard-Pascaud","year":"2005","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib242","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.HYP.37.6.1444","article-title":"ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats","volume":"37","author":"Park","year":"2001","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib243","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"10.1124\/pr.115.011106_bib244","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2215\/CJN.05760513","article-title":"Collecting duct principal cell transport processes and their regulation","volume":"10","author":"Pearce","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0303-7207(88)90119-0","article-title":"Inhibition of hormonal-induced cAMP and steroid production by inhibitors of pregnenolone metabolism in adrenal and Leydig cells","volume":"60","author":"Penhoat","year":"1988","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib246","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00424-014-1673-1","article-title":"Dietary potassium and the renal control of salt balance and blood pressure","volume":"467","author":"Penton","year":"2015","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.115.011106_bib247","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/HYPERTENSIONAHA.108.128520","article-title":"Endothelial epithelial sodium channel inhibition activates endothelial nitric oxide synthase via phosphoinositide 3-kinase\/Akt in small-diameter mesenteric arteries","volume":"53","author":"P\u00e9rez","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib248","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4161\/derm.15332","article-title":"Glucocorticoid receptors, epidermal homeostasis and hair follicle differentiation","volume":"3","author":"P\u00e9rez","year":"2011","journal-title":"Dermatoendocrinol"},{"key":"10.1124\/pr.115.011106_bib249","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1124\/jpet.103.056184","article-title":"Increased reactivity of murine mesenteric veins to adrenergic agonists: functional evidence supporting increased alpha1-adrenoceptor reserve in veins compared with arteries","volume":"308","author":"P\u00e9rez-Rivera","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.011106_bib250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1113\/jphysiol.2005.092692","article-title":"A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice","volume":"569","author":"Perrier","year":"2005","journal-title":"J Physiol"},{"key":"10.1124\/pr.115.011106_bib251","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib252","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10741-011-9286-7","article-title":"The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure","volume":"17","author":"Pitt","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1124\/pr.115.011106_bib253","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ejhf.218","article-title":"Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and\/or chronic kidney disease","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1124\/pr.115.011106_bib254","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011106_bib255","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011106_bib256","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jacc.2013.09.057","article-title":"Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis","volume":"63","author":"Pitt","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.115.011106_bib257","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011106_bib258","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/liv.12794","article-title":"Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis","volume":"35","author":"Pizarro","year":"2015","journal-title":"Liver Int"},{"key":"10.1124\/pr.115.011106_bib259","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","article-title":"Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension","volume":"304","author":"Preston","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/pr.115.011106_bib260","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.108.184044","article-title":"Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart","volume":"104","author":"Qu","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011106_bib261","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2012.05.011","article-title":"Aldosterone, oxidative stress, and NF-\u03baB activation in hypertension-related cardiovascular and renal diseases","volume":"53","author":"Queisser","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pr.115.011106_bib262","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.105.539122","article-title":"Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria","volume":"112","author":"Quinkler","year":"2005","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib263","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1475-2840-12-172","article-title":"Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes","volume":"12","author":"Ram\u00edrez","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pr.115.011106_bib264","first-page":"834","article-title":"Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells","volume":"76","author":"Rautureau","year":"2011","journal-title":"Steroids"},{"key":"10.1124\/pr.115.011106_bib265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","article-title":"Endothelial cell mineralocorticoid receptors regulate DOC\/salt-mediated cardiac remodeling and vascular reactivity, but not blood pressure","volume":"63","author":"Rickard","year":"2014","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib266","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib267","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/ndt\/gft035","article-title":"Aldosterone and the kidney: a rapidly moving frontier (an update)","volume":"29","author":"Ritz","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/pr.115.011106_bib268","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension","volume":"24","author":"Robert","year":"1994","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib269","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1152\/physrev.00011.2014","article-title":"Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited","volume":"95","author":"Rossier","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.115.011106_bib270","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/HYPERTENSIONAHA.108.114223","article-title":"Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes","volume":"52","author":"Rossier","year":"2008","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib271","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCULATIONAHA.111.028282","article-title":"Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study","volume":"125","author":"Rossignol","year":"2012","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011106_bib272","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.113.000792","volume":"7","author":"Rossignol","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1124\/pr.115.011106_bib273","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1242\/jcs.109.2.379","article-title":"Differential expression of epithelial sodium channel subunit mRNAs in rat skin","volume":"109","author":"Roudier-Pujol","year":"1996","journal-title":"J Cell Sci"},{"key":"10.1124\/pr.115.011106_bib274","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00424-007-0387-z","article-title":"Mineralocorticoid receptor is essential for corticosteroid-induced up-regulation of L-type calcium currents in cultured neonatal cardiomyocytes","volume":"456","author":"Rougier","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.115.011106_bib275","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000371497","article-title":"Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy","volume":"40","author":"Ruilope","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1124\/pr.115.011106_bib276","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2353\/ajpath.2007.060991","article-title":"Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia","volume":"171","author":"Sainte Marie","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.115.011106_bib277","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/ndt\/gfs014","article-title":"Recovery from ischemic acute kidney injury by spironolactone administration","volume":"27","author":"S\u00e1nchez-Pozos","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/pr.115.011106_bib278","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.107.093450","article-title":"Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction","volume":"50","author":"Sart\u00f3rio","year":"2007","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib279","first-page":"45","article-title":"Eplerenone improves vascular function and reduces platelet activation in diabetic rats","volume":"61","author":"Schafer","year":"2010","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/pr.115.011106_bib280","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","article-title":"Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity","volume":"34","author":"Sch\u00e4fer","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011106_bib281","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cjca.2012.06.009","article-title":"The immune system: role in hypertension","volume":"29","author":"Schiffrin","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1124\/pr.115.011106_bib282","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1124\/pr.115.011106_bib283","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0029-1243253","article-title":"Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists","volume":"42","author":"Schupp","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1124\/pr.115.011106_bib284","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.ackd.2014.08.003","article-title":"Aldosterone blockade in CKD: emphasis on pharmacology","volume":"22","author":"Schwenk","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1124\/pr.115.011106_bib285","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.164.3881.842","article-title":"Digitoxin poisoning: prevention by spironolactone","volume":"164","author":"Selye","year":"1969","journal-title":"Science"},{"key":"10.1124\/pr.115.011106_bib286","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ki.2011.505","article-title":"Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms","volume":"81","author":"Shavit","year":"2012","journal-title":"Kidney Int"},{"key":"10.1124\/pr.115.011106_bib287","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat Med"},{"key":"10.1124\/pr.115.011106_bib288","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cmet.2013.10.005","article-title":"Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia","volume":"18","author":"Shibata","year":"2013","journal-title":"Cell Metab"},{"key":"10.1124\/pr.115.011106_bib289","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1006\/jmcc.2000.1159","article-title":"Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertension and glucocorticoids","volume":"32","author":"Silvestre","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pr.115.011106_bib290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.02.006","article-title":"Steroidogenesis in the skin: implications for local immune functions","volume":"137","author":"Slominski","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/pr.115.011106_bib291","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbrc.2009.11.128","article-title":"MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression","volume":"391","author":"S\u00f5ber","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011106_bib292","doi-asserted-by":"crossref","first-page":"30363","DOI":"10.1074\/jbc.R110.155341","article-title":"Role of epithelial sodium channels and their regulators in hypertension","volume":"285","author":"Soundararajan","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011106_bib293","doi-asserted-by":"crossref","first-page":"H310","DOI":"10.1152\/ajpheart.01137.2009","article-title":"Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model","volume":"299","author":"Stein","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pr.115.011106_bib294","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.115.011106_bib295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1291\/hypres.30.427","article-title":"Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts","volume":"30","author":"Takeda","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1124\/pr.115.011106_bib296","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0026-895X(25)09737-8","article-title":"Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?","volume":"34","author":"Tal","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.115.011106_bib297","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.coph.2015.02.004","article-title":"Vascular mineralocorticoid receptor and blood pressure regulation","volume":"21","author":"Tarjus","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.115.011106_bib298","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00424-014-1616-x","article-title":"Role of smooth muscle cell mineralocorticoid receptor in vascular tone","volume":"467","author":"Tarjus","year":"2015","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.115.011106_bib299","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.115.05431","article-title":"Neutrophil gelatinase-associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids","volume":"66","author":"Tarjus","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib300","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00669.2014","article-title":"Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification","author":"Tatsumoto","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib301","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.00100.2011","article-title":"Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function","volume":"301","author":"Taves","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pr.115.011106_bib302","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.steroids.2009.09.008","article-title":"Aldosterone as a renal growth factor","volume":"75","author":"Thomas","year":"2010","journal-title":"Steroids"},{"key":"10.1124\/pr.115.011106_bib303","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-physiol-012110-142222","article-title":"Mechanisms underlying rapid aldosterone effects in the kidney","volume":"73","author":"Thomas","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/pr.115.011106_bib304","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/db06-0699","article-title":"Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes","volume":"56","author":"Thum","year":"2007","journal-title":"Diabetes"},{"key":"10.1124\/pr.115.011106_bib305","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/HYPERTENSIONAHA.109.140038","article-title":"Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin","volume":"54","author":"Tian","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib306","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI64162","article-title":"11\u03b2-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects","volume":"123","author":"Tiganescu","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.115.011106_bib307","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/HYPERTENSIONAHA.108.112664","article-title":"Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population","volume":"51","author":"Tobin","year":"2008","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib308","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tem.2013.09.006","article-title":"Genomic and epigenomic regulation of adipose tissue inflammation in obesity","volume":"24","author":"Toubal","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/pr.115.011106_bib309","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jacc.2009.09.045","article-title":"Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation","volume":"55","author":"Tsai","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.115.011106_bib310","doi-asserted-by":"crossref","first-page":"24248","DOI":"10.1016\/S0021-9258(18)35757-0","article-title":"Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone","volume":"267","author":"Ueda","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011106_bib311","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/HYPERTENSIONAHA.114.04981","article-title":"Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase","volume":"66","author":"Urbanet","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib312","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.115.011106_bib313","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.psyneuen.2010.10.003","article-title":"Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response","volume":"36","author":"van Leeuwen","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1124\/pr.115.011106_bib314","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","article-title":"Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)","volume":"60","author":"Vardeny","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.115.011106_bib315","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1053\/j.ajkd.2014.01.426","article-title":"Spironolactone to prevent peritoneal fibrosis in peritoneal dialysis patients: a randomized controlled trial","volume":"63","author":"Vazquez-Rangel","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/pr.115.011106_bib316","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.2013091023","article-title":"Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control","volume":"25","author":"Viengchareun","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib317","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.05012","article-title":"The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology","volume":"5","author":"Viengchareun","year":"2007","journal-title":"Nucl Recept Signal"},{"key":"10.1124\/pr.115.011106_bib318","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00424-009-0783-7","article-title":"Human endothelial dysfunction: EDCFs","volume":"459","author":"Virdis","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.115.011106_bib319","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1124\/pr.115.011106_bib320","first-page":"812","article-title":"Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice","volume":"123","author":"Voelkl","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.115.011106_bib321","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2215\/CJN.09421209","article-title":"A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients","volume":"5","author":"Vukusich","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011106_bib322","doi-asserted-by":"crossref","first-page":"F1072","DOI":"10.1152\/ajprenal.90643.2008","article-title":"Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats","volume":"296","author":"Waanders","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib323","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1124\/pr.115.011106_bib324","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1071-9164(03)00578-5","article-title":"Role of a selective aldosterone blocker in mice with chronic heart failure","volume":"10","author":"Wang","year":"2004","journal-title":"J Card Fail"},{"key":"10.1124\/pr.115.011106_bib325","doi-asserted-by":"crossref","first-page":"F1178","DOI":"10.1152\/ajprenal.00386.2003","article-title":"Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet","volume":"286","author":"Wang","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.115.011106_bib326","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrneph.2013.275","article-title":"Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells","volume":"10","author":"Warnock","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/pr.115.011106_bib327","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/clc.20762","article-title":"The effect of aldosterone antagonists for ventricular arrhythmia: a meta-analysis","volume":"33","author":"Wei","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1124\/pr.115.011106_bib328","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1124\/pr.115.011106_bib329","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pcad.2009.12.004","article-title":"Aldosterone: role in the cardiometabolic syndrome and resistant hypertension","volume":"52","author":"Whaley-Connell","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1124\/pr.115.011106_bib330","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.peptides.2012.04.008","article-title":"The retinal renin-angiotensin system: roles of angiotensin II and aldosterone","volume":"36","author":"Wilkinson-Berka","year":"2012","journal-title":"Peptides"},{"key":"10.1124\/pr.115.011106_bib331","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011106_bib332","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/clc.20914","article-title":"Effect of spironolactone on patients with atrial fibrillation and structural heart disease","volume":"34","author":"Williams","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1124\/pr.115.011106_bib333","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.ijcard.2013.08.027","article-title":"Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: a randomised placebo-controlled cross-over trial","volume":"168","author":"Wong","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1124\/pr.115.011106_bib334","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31815f2362","article-title":"Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study","volume":"32","author":"Yakirevich","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1124\/pr.115.011106_bib335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0028-1087188","article-title":"Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis","volume":"41","author":"Ye","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1124\/pr.115.011106_bib336","first-page":"5","article-title":"Effects of spironolactone on residual renal function and peritoneal function in peritoneal dialysis patients","volume":"30","author":"Yelken","year":"2014","journal-title":"Adv Perit Dial"},{"key":"10.1124\/pr.115.011106_bib337","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1527-5299.2005.03722.x","article-title":"Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure","volume":"11","author":"Yoshida","year":"2005","journal-title":"Congest Heart Fail"},{"key":"10.1124\/pr.115.011106_bib338","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.mce.2011.09.008","article-title":"Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis","volume":"350","author":"Young","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib339","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011106_bib340","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2009.05.006","article-title":"Mineralocorticoid receptors in the metabolic syndrome","volume":"20","author":"Zennaro","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/pr.115.011106_bib341","first-page":"1345","article-title":"Tissue-specific expression of alpha and beta messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states","volume":"82","author":"Zennaro","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/pr.115.011106_bib342","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mce.2011.04.023","article-title":"Aldosterone resistance: structural and functional considerations and new perspectives","volume":"350","author":"Zennaro","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pr.115.011106_bib343","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/EJE-12-0813","article-title":"Genetics of mineralocorticoid excess: an update for clinicians","volume":"169","author":"Zennaro","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/pr.115.011106_bib344","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/labinvest.2014.69","article-title":"The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis","volume":"94","author":"Zhang","year":"2014","journal-title":"Lab Invest"},{"key":"10.1124\/pr.115.011106_bib345","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1476-5381.2009.00551.x","article-title":"Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing","volume":"159","author":"Zhao","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011106_bib346","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1167\/iovs.11-7675","article-title":"Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina","volume":"52","author":"Zhao","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/pr.115.011106_bib347","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.115.011106_bib348","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in M\u00fcller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011106_bib349","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/aps.2012.36","article-title":"The mineralocorticoid receptor-p38MAPK-NF\u03baB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells","volume":"33","author":"Zhu","year":"2012","journal-title":"Acta Pharmacol Sin"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724011700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724011700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.115.011106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:45:11Z","timestamp":1739857511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724011700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":349,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0031699724011700"],"URL":"https:\/\/doi.org\/10.1124\/pr.115.011106","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.115.011106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}